Lantheus Completes Acquisition of Life Molecular Imaging. Please see the press release to learn more.

Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

August 6, 2025

Read More at Our Investor Site

Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time

July 23, 2025

Read More at Our Investor Site

Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D

July 22, 2025

Read More at Our Investor Site

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

June 11, 2025

Read More at Our Investor Site

For access to press releases before 2022 and full-text search capabilities, please visit our investor site.



Receive Email Alerts

Media Contact

Melissa Downs

Senior Director, Corporate Communications
646-975-2533

media@lantheus.com

Investors

Mark Kinarney

Vice President, Investor Relations
978-671-8842

ir@lantheus.com